 Susan Calcaterra
Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Opioid-Related Disorders | 21 | 2023 | 417 | 8.530 |
Why?
| | Buprenorphine | 12 | 2023 | 136 | 5.840 |
Why?
| | Analgesics, Opioid | 30 | 2023 | 794 | 4.940 |
Why?
| | Methadone | 9 | 2023 | 69 | 3.280 |
Why?
| | Hospitalists | 5 | 2021 | 173 | 2.770 |
Why?
| | Addiction Medicine | 3 | 2024 | 10 | 2.620 |
Why?
| | Opiate Substitution Treatment | 8 | 2023 | 96 | 2.340 |
Why?
| | Substance Withdrawal Syndrome | 6 | 2023 | 157 | 1.960 |
Why?
| | Substance-Related Disorders | 7 | 2022 | 971 | 1.580 |
Why?
| | Hospitalization | 10 | 2023 | 1785 | 1.390 |
Why?
| | Medical Marijuana | 2 | 2020 | 102 | 1.270 |
Why?
| | Patient Discharge | 6 | 2023 | 796 | 1.250 |
Why?
| | Central Nervous System Stimulants | 3 | 2015 | 142 | 1.240 |
Why?
| | Drug Overdose | 6 | 2019 | 294 | 1.090 |
Why?
| | Referral and Consultation | 4 | 2022 | 648 | 1.020 |
Why?
| | Chronic Pain | 6 | 2022 | 211 | 1.000 |
Why?
| | Hospital Medicine | 3 | 2022 | 84 | 0.950 |
Why?
| | Practice Patterns, Physicians' | 9 | 2022 | 1200 | 0.950 |
Why?
| | Hospitals | 6 | 2024 | 598 | 0.920 |
Why?
| | Cause of Death | 3 | 2013 | 380 | 0.850 |
Why?
| | Benzodiazepines | 2 | 2022 | 122 | 0.800 |
Why?
| | Prisoners | 2 | 2014 | 128 | 0.770 |
Why?
| | Prescription Drug Misuse | 2 | 2018 | 38 | 0.750 |
Why?
| | Humans | 50 | 2024 | 118974 | 0.740 |
Why?
| | Medicine | 1 | 2021 | 106 | 0.700 |
Why?
| | Decision Support Systems, Clinical | 1 | 2022 | 178 | 0.700 |
Why?
| | Drug Substitution | 1 | 2019 | 46 | 0.700 |
Why?
| | Pain Management | 4 | 2022 | 294 | 0.660 |
Why?
| | Healthcare Disparities | 1 | 2024 | 496 | 0.640 |
Why?
| | Internationality | 1 | 2019 | 152 | 0.640 |
Why?
| | Qualitative Research | 6 | 2022 | 953 | 0.640 |
Why?
| | Poison Control Centers | 1 | 2018 | 84 | 0.600 |
Why?
| | Burnout, Professional | 1 | 2022 | 330 | 0.590 |
Why?
| | Naloxone | 5 | 2020 | 98 | 0.570 |
Why?
| | Adult | 21 | 2022 | 31512 | 0.570 |
Why?
| | Global Health | 1 | 2019 | 310 | 0.570 |
Why?
| | Cancer Survivors | 1 | 2020 | 201 | 0.560 |
Why?
| | Retrospective Studies | 15 | 2022 | 12978 | 0.550 |
Why?
| | Electronic Health Records | 3 | 2022 | 829 | 0.540 |
Why?
| | Marijuana Smoking | 1 | 2019 | 220 | 0.540 |
Why?
| | Narcotic Antagonists | 5 | 2021 | 136 | 0.520 |
Why?
| | Drug Users | 1 | 2015 | 39 | 0.500 |
Why?
| | Emergency Service, Hospital | 4 | 2023 | 1865 | 0.500 |
Why?
| | Perception | 1 | 2017 | 314 | 0.490 |
Why?
| | Physicians | 1 | 2022 | 794 | 0.480 |
Why?
| | Acute Pain | 3 | 2018 | 33 | 0.470 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 628 | 0.460 |
Why?
| | Alcohol Drinking | 1 | 2019 | 652 | 0.460 |
Why?
| | Cannabis | 1 | 2020 | 382 | 0.450 |
Why?
| | Alcoholism | 2 | 2023 | 717 | 0.450 |
Why?
| | Patient Satisfaction | 1 | 2017 | 610 | 0.440 |
Why?
| | Databases, Factual | 3 | 2017 | 1231 | 0.410 |
Why?
| | Prescription Drugs | 1 | 2013 | 113 | 0.390 |
Why?
| | Mental Health Services | 1 | 2015 | 331 | 0.390 |
Why?
| | Middle Aged | 14 | 2020 | 27617 | 0.370 |
Why?
| | Pain | 1 | 2016 | 735 | 0.370 |
Why?
| | Cocaine | 1 | 2012 | 158 | 0.360 |
Why?
| | Consensus | 3 | 2022 | 534 | 0.350 |
Why?
| | Female | 19 | 2020 | 61565 | 0.350 |
Why?
| | United States | 9 | 2024 | 12555 | 0.340 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 687 | 0.340 |
Why?
| | Male | 19 | 2020 | 57801 | 0.340 |
Why?
| | Young Adult | 8 | 2020 | 10793 | 0.300 |
Why?
| | Inappropriate Prescribing | 2 | 2017 | 51 | 0.280 |
Why?
| | Forecasting | 2 | 2018 | 353 | 0.280 |
Why?
| | Stress, Psychological | 1 | 2014 | 972 | 0.270 |
Why?
| | Colorado | 5 | 2019 | 4196 | 0.270 |
Why?
| | Analgesics | 2 | 2017 | 159 | 0.250 |
Why?
| | Adolescent | 8 | 2020 | 18480 | 0.230 |
Why?
| | Surveys and Questionnaires | 4 | 2020 | 4708 | 0.230 |
Why?
| | Narcotics | 1 | 2023 | 50 | 0.220 |
Why?
| | Interviews as Topic | 2 | 2016 | 599 | 0.220 |
Why?
| | Aftercare | 1 | 2023 | 194 | 0.200 |
Why?
| | Social Workers | 1 | 2021 | 28 | 0.200 |
Why?
| | Morpholines | 1 | 2022 | 106 | 0.200 |
Why?
| | Pharmacists | 2 | 2021 | 238 | 0.200 |
Why?
| | Patients | 1 | 2023 | 175 | 0.200 |
Why?
| | Communication Barriers | 1 | 2022 | 94 | 0.200 |
Why?
| | Cost-Benefit Analysis | 2 | 2023 | 554 | 0.200 |
Why?
| | Social Stigma | 1 | 2021 | 87 | 0.190 |
Why?
| | Prescriptions | 1 | 2020 | 63 | 0.190 |
Why?
| | Drug Administration Schedule | 3 | 2018 | 736 | 0.180 |
Why?
| | Nausea | 1 | 2020 | 107 | 0.180 |
Why?
| | Interrupted Time Series Analysis | 1 | 2019 | 45 | 0.170 |
Why?
| | Time | 1 | 2018 | 77 | 0.170 |
Why?
| | Attitude | 1 | 2020 | 231 | 0.160 |
Why?
| | Safety-net Providers | 1 | 2019 | 96 | 0.160 |
Why?
| | Patient Preference | 2 | 2018 | 170 | 0.160 |
Why?
| | Terminology as Topic | 1 | 2019 | 211 | 0.150 |
Why?
| | Quality of Life | 2 | 2020 | 2366 | 0.150 |
Why?
| | Cohort Studies | 3 | 2018 | 5116 | 0.150 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2017 | 39 | 0.150 |
Why?
| | Counseling | 1 | 2020 | 353 | 0.150 |
Why?
| | Ambulatory Care | 1 | 2020 | 482 | 0.140 |
Why?
| | South Carolina | 1 | 2016 | 38 | 0.140 |
Why?
| | Regression Analysis | 1 | 2019 | 983 | 0.140 |
Why?
| | Drug Utilization | 1 | 2017 | 169 | 0.140 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2019 | 1945 | 0.140 |
Why?
| | Survival Rate | 1 | 2020 | 1720 | 0.140 |
Why?
| | Prospective Studies | 2 | 2020 | 6471 | 0.130 |
Why?
| | Community Health Planning | 1 | 2015 | 44 | 0.130 |
Why?
| | General Practice | 1 | 2015 | 26 | 0.130 |
Why?
| | Primary Health Care | 3 | 2023 | 1560 | 0.130 |
Why?
| | Prognosis | 2 | 2020 | 3443 | 0.130 |
Why?
| | Internal Medicine | 1 | 2017 | 215 | 0.130 |
Why?
| | Aged | 5 | 2020 | 19657 | 0.120 |
Why?
| | Inpatients | 1 | 2018 | 388 | 0.120 |
Why?
| | Societies, Medical | 1 | 2018 | 703 | 0.120 |
Why?
| | Unemployment | 1 | 2014 | 42 | 0.120 |
Why?
| | Quality Indicators, Health Care | 1 | 2017 | 295 | 0.120 |
Why?
| | Drug Prescriptions | 1 | 2016 | 248 | 0.120 |
Why?
| | Guideline Adherence | 1 | 2018 | 523 | 0.120 |
Why?
| | Topography, Medical | 1 | 2013 | 11 | 0.110 |
Why?
| | Community Health Services | 1 | 2015 | 212 | 0.110 |
Why?
| | Housing | 1 | 2014 | 123 | 0.110 |
Why?
| | Respiratory Insufficiency | 1 | 2016 | 290 | 0.110 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 4552 | 0.100 |
Why?
| | Washington | 1 | 2012 | 141 | 0.100 |
Why?
| | Internship and Residency | 1 | 2022 | 1001 | 0.100 |
Why?
| | Risk Factors | 3 | 2018 | 9000 | 0.100 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4596 | 0.100 |
Why?
| | Drug Interactions | 1 | 2012 | 352 | 0.100 |
Why?
| | Interpersonal Relations | 1 | 2014 | 345 | 0.100 |
Why?
| | Aged, 80 and over | 2 | 2018 | 6561 | 0.090 |
Why?
| | Infant, Newborn | 1 | 2020 | 5255 | 0.090 |
Why?
| | Proportional Hazards Models | 1 | 2012 | 1125 | 0.080 |
Why?
| | Survival Analysis | 1 | 2012 | 1267 | 0.080 |
Why?
| | Pregnancy | 1 | 2020 | 5691 | 0.080 |
Why?
| | Sex Characteristics | 1 | 2013 | 671 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1185 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2015 | 3171 | 0.080 |
Why?
| | Anti-Bacterial Agents | 1 | 2017 | 1510 | 0.080 |
Why?
| | Time Factors | 1 | 2016 | 6412 | 0.070 |
Why?
| | Phenobarbital | 1 | 2023 | 18 | 0.060 |
Why?
| | Life Expectancy | 1 | 2023 | 52 | 0.060 |
Why?
| | Weight-Bearing | 1 | 2003 | 172 | 0.050 |
Why?
| | Arthritis, Experimental | 1 | 2003 | 133 | 0.050 |
Why?
| | Osteoarthritis | 1 | 2003 | 176 | 0.050 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 304 | 0.050 |
Why?
| | Logistic Models | 2 | 2016 | 1901 | 0.050 |
Why?
| | International Classification of Diseases | 1 | 2019 | 122 | 0.040 |
Why?
| | Medical Audit | 1 | 2017 | 75 | 0.040 |
Why?
| | Health Transition | 1 | 2016 | 7 | 0.040 |
Why?
| | Prescription Drug Overuse | 1 | 2016 | 12 | 0.040 |
Why?
| | Medical Records | 1 | 2017 | 163 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2019 | 2874 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2018 | 555 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2017 | 422 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2016 | 546 | 0.030 |
Why?
| | Models, Statistical | 1 | 2018 | 636 | 0.030 |
Why?
| | Health Surveys | 1 | 2015 | 454 | 0.030 |
Why?
| | Communication | 1 | 2018 | 761 | 0.030 |
Why?
| | Odds Ratio | 1 | 2015 | 996 | 0.030 |
Why?
| | Program Evaluation | 1 | 2017 | 845 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1474 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 992 | 0.020 |
Why?
| | Patient Education as Topic | 1 | 2015 | 699 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2015 | 781 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3057 | 0.020 |
Why?
| | Iodoacetates | 1 | 2003 | 4 | 0.020 |
Why?
| | Hindlimb | 1 | 2003 | 137 | 0.010 |
Why?
| | Rats, Wistar | 1 | 2003 | 399 | 0.010 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2003 | 116 | 0.010 |
Why?
| | Acetaminophen | 1 | 2003 | 244 | 0.010 |
Why?
| | Disease Progression | 1 | 2003 | 2490 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2003 | 2674 | 0.010 |
Why?
| | Rats | 1 | 2003 | 5392 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2003 | 9342 | 0.010 |
Why?
| | Animals | 1 | 2003 | 33381 | 0.000 |
Why?
|
|
Calcaterra's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|